A mid-sized pharma client was working to develop their asset portfolio, and was interested to assess best possible asset for atrial fibrillation [...]
A large pharma client was working to develop their cyclophosphamide API and FD, and was interested to assess competitive products [...]
A medium pharmaceutical client based in United States with biosimilar commercial capabilities involved DelveInsight to identify commercial processes [...]
A Small Pharmaceutical Client Based At Sweden, Europe With Capabilities Around A Neonatal Mesenchymal Cells Involved DelveInsight [...]